Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer

Listen to D. Ross Camidge, MD, PhD, and Joel W. Neal, MD, PhD, address questions from learners on investigational antibody–drug conjugates for advanced NSCLC.